Howard S. Hochster, MD of Yale Cancer Center discusses the difference between Regorafenib, 5FU, and TAS-102 at the 2017 Gastrointestinal Cancers Symposium (Annual Meeting GI) in San Francisco, CA.
Difference between Regorafenib, 5FU, and TAS-102
Advertisement
[the_ad id="32629"]